By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
What do baseball, broadcast journalism, and biotech have in common? All are part of the life and unconventional career journey of David Lucchino, cofounder and CEO of Frequency Therapeutics (NASDAQ: FREQ). It’s a path that bucks conventional wisdom, much like what Frequency is trying to do with its goal to restore hearing loss — something previously considered impossible.